Axsome settles patent litigation with Teva over AUVELITY
NEW YORK - Axsome Therapeutics, Inc. (NASDAQ:AXSM), a $5.1 billion market cap biopharmaceutical company with impressive 91% gross profit margins, has reached a settlement agreement with Teva ...
Muddy Waters Capital buying at Mayfair Gold (MFG)
Real-time index price for Nasdaq US MD Cap Telecom Index USD (NQTI), along with buy or sell indicators, analysis, charts, historical performance, news and more ...
Tenable: Q4 Earnings Snapshot
The average estimate of nine analysts surveyed by Zacks Investment Research was for earnings of 34 cents per share. The cybersecurity software company posted revenue of $235.7 million in the period, ...
Formwork Plywood Market is Expected to Grow at 2.1% CAGR with US$ 7,850.5 Million by 2034 ...
As governments prioritize infrastructure improvements, the demand for efficient and durable formwork solutions will continue to rise, presenting significant opportunities for manufacturers and ...
FDA approves United Therapeutics' xeno-organ trial
Corporation (NASDAQ: UTHR) has received clearance from the U.S. Food and Drug Administration (FDA) to begin a pioneering clinical trial of its gene-edited xenotransplantation kidney, named UKidney, ...